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Abstract 
Methanol, chloroform and water extracts of Acacia nilotica sub 
species tomentosa were tested in-vitro for their potential antiviral activity 
against the Komarov vaccine strain of Newcastle disease virus (NDV). Sub 
culturing the treated samples and heamagglutination test were used to 
evaluate the reduction of viability in the viral growth in presence and 
absence of the effective extract. The noncytotoxic concentration of each 
extract was determined by the absence of the CPE. The inhibitory 
concentration of the effective extract was measured. The tannin percentage 
of the methanol and water extracts were evaluated by Prussian Blue assay. 
The methanol extract of Acacia nilotica on vero cells showed non- 
cytotoxic concentration of ≥   40µg/ml. The methanol extract showed a 
significant inhibitory effect against the tested virus at the concentration of 40 
µg/ml. None of the other two extracts showed any inhibitory activity. 
Subculturing of the treated samples of the methanol extract showed no CPE 
compared to the control. The HA test showed zero titer of the tested samples 
against 2 log 6 to the control. 
The tannin percentage of the methanol extract were higher (1.6%) 
than the water extract percentage (1.2%).   
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  ﻣﻠﺨﺺ اﻻﻃﺮوﺣﺔ
 
 
  
ﻟﻨﺒﺎت اﻻآﺎﺳﻴﺎ ( اﻟﻤﻴﺜﺎﻧﻮل، اﻟﻜﻠﻮروﻓﻮرم، اﻟﻤﺎء) ﻓﻰ هﺬﻩ اﻟﺪراﺳﺔ ﺗﻢ اﺧﺘﺒﺎر ﺛﻼﺛﺔ ﻣﻦ اﻟﻤﺴﺘﺨﻠﺼﺎت-
  .ﻣﻌﻤﻠﻴﺎ ﻟﺘﺤﺪﻳﺪ اﻻﺛﺮ اﻟﻤﻀﺎد ﻟﻠﻔﻴﺮوﺳﺎت ﺿﺪ ﻋﺘﺮة آﻮﻣﺎروف اﻟﻠﻘﺎﺣﻴﺔ ﻟﻔﻴﺮوس ﻣﺮض اﻟﻨﻴﻮآﺎﺳﻞ
ﺛﺮ اﻟﻔﻴﺮوس ﺑﻌﺪ ﻣﻌﺎﻟﺠﺘﻪ اﻋﺎدة اﺳﺘﺰراع اﻟﻔﻴﺮوس واﺧﺘﺒﺎر اﻟﺘﻼزن اﻟﺪﻣﻮى اﺛﺒﺘﺎ اﻧﺨﻔﺎض ﺗﻜﺎ-
  .ﺑﺎﻟﻤﺴﺘﺨﻠﺺ اﻟﻔﻌﺎل
ﻣﺴﺘﺨﻠﺺ اﻟﻤﻴﺜﺎﻧﻮل ﻟﻠﻨﺒﺎت اﺛﺒﺖ ﻓﻌﺎﻟﻴﺔ ﺿﺪ اﻟﻌﺘﺮة اﻟﻤﺴﺘﺨﺪﻣﺔ ﻓﻰ ﺗﺮآﻴﺰ ﻏﻴﺮ ﺳﺎم ﻟﻠﺨﻼﻳﺎ اﻟﻤﺴﺘﺨﺪﻣﺔ -
اﻟﻤﺴﺘﺨﻠﺼﻴﻦ اﻻﺧﺮﻳﻦ ﻟﻢ ﻳﻌﻄﻴﺎ اى ﻧﺘﻴﺠﺔ ﺿﺪ اﻟﻌﺘﺮة . ﻣﻞ/ ﻣﻴﻜﺮوﺟﺮام04ﻓﻰ اﻟﺘﺠﺮﺑﺔ وهﻮ ﺗﺮآﻴﺰ 
  .اﻟﻤﺴﺘﺨﺪﻣﺔ ﻓﻰ اﻟﺘﺮآﻴﺰ اﻟﻐﻴﺮ ﺳﺎم ﻟﻠﺨﻼﻳﺎ
 اﻋﺎدة اﻻﺳﺘﺰراع ﻟﻠﻌﺘﺮة اﻟﻤﻌﺎﻟﺠﺔ ﺑﺎﻟﻤﺴﺘﺨﻠﺺ اﻟﻔﻌﺎل ﻟﻢ ﻳﻈﻬﺮ اى اﺛﺮ ﻣﻤﺮض ﻟﻠﺨﻼﻳﺎ ﻣﻘﺎرﻧﺔ -
اﺧﺘﺒﺎر اﻟﺘﻼزن اﻟﺪﻣﻮى اﻇﻬﺮ ﻋﻴﻬﺮﻳﺔ ﺻﻔﺮ ﺑﺎﻟﻨﺴﺒﺔ ﻟﻠﻌﻴﻨﺎت . ﺑﺎﻟﻜﻮﻧﺘﺮول اﻟﻤﺤﺘﻮى ﻋﻠﻰ ﻋﺘﺮة ﺣﻴﺔ
  .62ﻟﻐﻴﺮ ﻣﻌﺎﻟﺠﺔ ﺑﺎﻟﻤﺴﺘﺨﻠﺺ و اﻟﺘﻰ اﻇﻬﺮت ﻋﻴﺎرﻳﺔ ااﻟﻤﻌﺎﻟﺠﺔ ﺑﺎﻟﻤﺴﺘﺨﻠﺺ ﻣﻘﺎرﻧﺔ ﺑﺎﻟﻌﻴﻨﺎت 
 ﺗﻢ ﺗﺤﺪﻳﺪ ﻧﺴﺒﺔ اﻟﺘﺎﻧﻴﻦ ﻓﻰ ﻣﺴﺘﺨﻠﺼﻰ اﻟﻤﻴﺜﺎﻧﻮل واﻟﻤﺎء وآﺎﻧﺖ اﻟﻨﺴﺒﺔ اﻋﻠﻰ ﻓﻰ ﻣﺴﺘﺨﻠﺺ اﻟﻤﻴﺜﺎﻧﻮل  -
  %(.2.1)ﻣﻘﺎرﻧﺔ ﺑﺎﻟﻤﺴﺘﺨﻠﺺ اﻟﻤﺎﺋﻲ %( 6.1)
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CHAPTER ONE 
 LITREATURE REVIEW 
 
1. Acacia nilotica 
1.1. General information of the plant 
1.1.1 Scientific classification 
The plant classified by Brenan, 1957 as follows: 
Kingdom: Plantae. 
Phylum: Magnoliophyta. 
Class: Magnoliopsida. 
Order: Fabales. 
Family: Fabaceae.\ Leguminosae. 
Sub family: Mimosoideae. 
Tribe: Acacieae. 
Genus: Acacia. 
Species: A.nilotica. 
Sub species: tomentosa 
Latin name: Acacia nilotica (L.) willd exDell. 
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Local name: sunot – Garad (fruits). 
 
1.2 Botanical descriptions 
Small tree (2.5-14m) tall and it has branches full of long sharp thorns. 
It can grow up to 20 meters but this attenuated by site; it is usually no more 
than 10 meters high and in very unfavorable locations is only a shrub. It has 
a flattish or umbrella shaped crown and it easily identified by its bright 
yellow sweet scented flower heads (El Amin, 1973). 
1. 2.1 Leaves  
Often with 1-2 petiolar glands and other glands between all or only 
the upper most pinnae, pinnae (2-11) pairs, leaflets (7-52) pairs(0.5-1.5)mm 
wide, glabrous or pubscent apex obtuse. 
Peduncles clustered at notes of leafy and leafless branches (Duke, 1981). 
1.2.2 Flowers 
 Bright or golden yellow, sweetly scented, numerous, with bisexual 
and male flowers on the same globose inflorescence. Flowering is prolific, 
can occur a number of times in a season on current seasons growth, but often 
only about 0.1% of flowers set pods (Tybirk, 1989). 
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1.2.3 Fruits 
Pods are grey, thick, softly tomentose, and straight or slightly curved, 
10-15 cm long on a pedical, 0.5-1.2 cm long, with constrictions between the 
seeds, giving a necklace appearance. Fleshy when young, becoming black 
and hard when maturity (Andrews, 1952). 
1.2.4 Seeds 
 Seeds are deep blackish-brown, smooth, sub circular, compressed 
areole (6-7) mm wide (Duke, 1981). 
1.2.5 Maturity age 
 Maturation takes 8 months (ideal) to 12 years (harsh conditions). 5-7 years 
are typical (Kriticos et al, 1999). 
1.3 Habitat 
Lowland plants (El ghazali et al, 1994). In Africa, sub species nilotica 
and tomentosa are restricted to riverine habitats and seasonally flooded areas 
on clay alluvial soils (Fagg et al, 1990). 
1.4. Distribution 
 A.nilotica is native to Africa including Egypt, Mozambique, Sudan, 
Natal, Zambia and Botswana (Duke, 1983). 
 The sub species tomentosa occurs in Senegal, Mali, Ivory Coast, 
Ghana, Niger, Nigeria, the Sudan and Ethiopia (El Amin, 1973).  
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1.4.1 Distribution in Sudan 
 It is widely distributed along the Nile bank and its tributaries, 
especially in northern and central Sudan (Sayda Mahjoub et al, 1996).   
1.5 Ecology 
A.nilotica is a relatively fast growing, nitrogen-fixing tree on arid 
sites. It is a moderate-sized tree, that can withstand extreme environment, 
favors in semi-arid areas. Can survive very arid sites, thrives under irrigation 
and endures floods. It is an important riverine tree in Egypt, India, Sudan 
and Senegal (Duke, 1983). 
1.6. Temperature 
Trees can withstand extremes of temperatures, but are frost tender 
when young. Average annual temperatures commonly vary from 15o to 28oC 
(Duke, 1983). 
Acacia nilotica prefers dry conditions, with an annual rainfall of from 
250 to 1500 mm, although under irrigation some varieties will grow in areas 
with less than 100 mm (Duke, 1983). 
1.7 PH range 
  From 2.5 to 8.0 (Duke, 1983). 
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1.8 Uses 
1.8.1 Firewood-Charcoal 
   Excellent firewood and charcoal. Used to fuel locomotives, river 
steamers and boilers in some small industries (Firewood crops). 
 
1.8.2 Timber-Wood 
   Hard and tough wood. Resistant to termites, water. 
Popular for railroad, tool handles, carts, oars, posts and buildings. Attractive 
wood good for carving, turnery and boat building (Firewood crops.). 
1.8.3 Pulp and paper 
 Wood is good for paper and pulp making (Dwivedi, 1993). 
1.8.4 Forage-Fodder 
 Leaves, tender pods and shoots used as forage for goats, sheep and 
camels. Seeds are also a valuable cattle food (Duke, 1983). Pods contain 12-
15% crude protein. Rich in minerals (Firewood crops). 
1.8.5 Tannins 
 Bark has high levels of tannin (12-20%) for sub species indica .Used 
for tanning and dyeing leathers. Pods of sub species nilotica used for tanning 
(Firewood crops). 
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1.8.6 Folk medicinal uses 
 The Zulu of South Africa take the bark for cough. An astringent    
from the bark used for diarrhea, dysentery and leprosy. Bruised leaves 
poultice are put on ulcers (Duke, 1983). 
According to Hart well, the gum or bark used for cancers and tumors 
of ear, eye or testicles, and indurations of liver and spleen, Candylomas and 
excess flesh. Other ailments treated by these products include, cold, 
congestion, cough, diarrhea, dysentery, fever, hemorrhage, hemorrhoid, 
ophthalmia, sclerosis and in Somalia, the wood is used to treat small pox. 
Sap and bark, leaves and young pods are strongly astringent due to tannin, 
and in Senegal are chewed as an antiscorbutic, and in Ethiopia as a 
lactogogue. (Duke, 1983).   
Massai of East Africa uses a bark decoction drunk for intestinal pains, 
diarrhea, and nerve stimulant. 
Other preparation used for coughs, as a gargle, toothache and for 
ophthalmatic and syphilitic ulcers. In Tonga, the root is used to treat 
tuberculosis. In Lebanon the resin is mixed with an orange-flower, infusion 
for typhoid convalesces. Egyptian Nubians believe that diabetics may eat 
unlimited carbohydrates without any consequences as long as they consume 
the pods in powder form (Duke, 1983).  
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Extracts are inhibitory four species of pathogenic fungi (Umalker, et 
al 1976).  
Extracts of the fruits, rich in tannin (18-23%) has medicinal use as a 
powerful astringent, molluscide and algaecide (Duke, 1983) (Fagg, et al 
1992). 
  The fruits given for diarrhea, hemorrhage, and as sedative in labor, 
and as a cure for sore gum and loose teeth (Duke, 1983). 
Fruits can use for diabetes by taking teaspoonful before breakfast. 
The leaflets are chewn for nausea (Duke, 1983). 
1.9 Limitations-Concerns- Additional information  
Trees are extremely thorny and could become a major problem when 
introduced to areas where people do not traditionally use thorn trees (Fagg, 
et al, 1992).  
1.10Chemical constituents 
   Acacia nilotica has reported to contain 1-arabinose, catechol, 
galactan, galacto araban, galactose, N-acetyldjenkolic acid, sulphoxides 
pentosan, saponin and tannin (Pande et al, 1981).. 
Seeds contain crude protein, fiber, nitrogen-free extract, ash and 
silica, epoxy and hydroxy fatty acid (Pande et al, 1981).  
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Various flavonoids and phenolic compounds isolated from the 
flowers. The bark and sap contain quercetin and saponins (Watt et al, 1957). 
Pods contain Gallic acid and m-diagallic acid (El ghazali, et al, 1994). 
 Catechins-s-galloyl esters were isolated from the bark (Khalid, et al, 1989). 
 
1.11 Anti microbial activity for Acacia nilotica 
Aqueous extracts of fruits (collected from central Sudan) showed 
activity against Candida albicans and gram +ve and gram –ve bacteria 
(Abdel Nabi, et al, 1999). 
The aqueous extract showed considerable inhibitory effect against 
HIV-1. (Hussein et al, 1999). 
1.11 Hepato protective activity 
  There was a study show that the methanolic extract from leaves of 
Acacia nilotica exerts hepato protective effects against carbon tetra chloride 
CCl4 induced liver injury in rats (Abdel Razik, et al 2006). 
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2. NEWCASTLE DISEASE 
2.1 Introduction 
Newcastle disease (ND) is one of the most important diseases of 
poultry worldwide ever since the advent of high-density, confinement 
husbandry systems (Murphy et al, 1999). 
The disease is highly contagious; spreading rapidly among susceptible 
birds and can cause mortality up to 100%. Gastro- intestinal, respiratory and 
nervous signs characterize the disease (Murphy et al, 1999). 
2.2 History of the disease 
Outbreaks of Newcastle disease first reported in poultry in Java, 
Indonesia and Newcastle-upon-Tyne in 1926.The disease currently has 
worldwide distribution (Seal et al, 2000). The disease took over 30 years to 
cover most countries of Europe, Middle East and North America 
(Alexander, 1991). 
There were reports of disease outbreaks in central Europe similar to 
what recognized in Java in 1926.The disease might have been present in 
Korea as early as 1924 (Alexander, 1997). Within 10 years from its first 
occurrence, the disease had been reported In Japan, East Africa and 
Australia (Beard and Hanson, 1984). 
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The name Newcastle was coined by Doyle as a temporary measure to 
avoid confusion in description with other diseases (Doyle, 1935), that were 
caused by viruses indistinguishable from Newcastle disease virus (NDV) 
(Alexander, 1997). 
 In the United States, a relatively mild respiratory disease often with 
nervous signs, was first described in the 1930 and subsequently termed 
pneumoencephalities (Beach, 1942) which was shown to be due to a virus 
indistinguishable from NDV in serologic tests (Beach, 1944). Within a few 
years, numerous NDV isolations that produced extremely mild or no disease 
in chickens were made around the world (McFerran, and Nelson, 1971). 
Difference in NDV type and the severity of the disease it produces, has 
caused some problems with the nomenclature, usually when the disease was 
first recognized in a country (Alexander, 1997). As a result, Newcastle 
disease has been termed pseudo fowl pest, pseudo Vogel-pest, atypische 
Geflugel pest, pseudo poultry plague, avian pest, avian distemper, Ranikhet 
disease, Tetlodisease, Korean fowl plague, and avian pneumoencephalitis 
(Alexander, 1997). 
2.3 Causative agent 
Newcastle disease caused by avian paramyxovirus serotype-1 
(APMV-1) viruses, which is included in list A of the Office International des 
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Epizooties (OIE). Eight other serotypes of avian paramyxoviruses are 
recognized, namely APMV-2 to APMV-9. Most of these serotypes appear to 
be present in natural reservoirs of specific feral avian species, although other 
host species are usually susceptible. Only APMV-2 and APMV-3 viruses 
have made a significant disease and economic impact on poultry production 
(Alexander et al, 2000). 
2.3.1 Classification of the virus  
NDV is a member of the genus Rubulavirus (Aviulavirus) of the 
family paramyxoviridae (Rima et al, 1995) which belongs to the order 
Mononegavirales (Murphy et al, 1999; Alexander, 1997). The genus 
Rubulavirus is greatly similar to other two genera of the subfamily 
Paramyxovirinae (Paramyxovirus and Morbilivirus) (Pringle, 1997). genus 
Rubulavirus includes Newcastle disease virus (NDV), Avian 
paramyxoviruses 2-9, Canine parainfluenzavirus 2, porcine rubulavirus, 
Mumps virus and human parainfluenzavirus 2, 4a and 4b (Murphy et al, 
1999). 
Recent study of the whole Newcastle disease virus genome sequence 
has suggested that avian paramyxoviruses are sufficiently different from 
other Rubulaviruses so they could placed in a separate genus (De Leeuw and 
Peeters, 1999).NDV lacks a gene encoding for small hydrophobic protein 
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occasionally present in members of rubulaviruses (Lamb and Kolakofsky, 
1996).  There is a suggestion to group paramyxoviruses based on their 
antigenic relatedness in hemagglutination inhibition test (HI) (Tumova et al, 
1979). 
However, similar groups have been resulted when the following tests 
have been used neuraminidase inhibition (Ishida et al, 1985; Kessler et al, 
1979; Tumova et al, 1979), serum neutralization (Tumova et al, 1979) and 
agar gel diffusion (Abense et al, 1983; Alexander et al, 1983; Ishida et al, 
1985 and Kida and Yanagwa 1981). Despite the serologic grouping, there 
are some cross relationships have been demonstrated between viruses of 
different serotypes (Alexander, 1997). Some serological relationships have 
been demonstrated between NDV (PMV-1) and other paramyxovirus 
serotypes, the most significant being that with the viruses of PMV-3 
serotypes (Smit and Rondhuis, 1976; Alexander and Chettle, 1978; Jordan 
1990). 
2.3.2 Virion  
2.3.2.1 Size 
Paramyxoviridae are generally spherical and 150-350 nanometer in 
diameter (Lamb et al, 2002) (Waterson and Cruickshank, 1963). 
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2.3.2.2 Shape 
Paramyxoviridae are generally spherical, but they can be pleomorphic, 
and filamentous forms can be observed. Inserted into the envelope are 
glycoprotein spikes (peplomers)  that extend about 8 to 12 nanometer from 
the surface of the membrane and that can be readily visualized by electron 
microscopy (Lamb et al, 2002). The nucleocapsid contains a “herring bone-
shaped” with a helical symmetry (Murphy et al, 1999), and may be seen 
either free or emerging from disrupted particles (Alexander, 1997). 
2.3.2.3 Structure of the genome 
The genome consists of a single linear molecule of negative sense, 
single stranded RNA, 15-16 Kb in size (Murphy et al, 1999) (Seal et al, 
2000). The NDV is composed of 15186 nucleotides (Phillips et al, 1998). 
The genome of NDV codes for six proteins (Kolakofsky, 1974), three 
of them are associated with the lipid envelope of the virion (Millar et al, 
1988).  
The proteins are large protein (L), hemagglutinin neuraminidase (HN), 
fusion protein (F), matrix protein (M), phospho protein (P), and nucleo 
protein (N) (Samson, 1988). The hemagglutinin-neuraminidase and fusion 
glycoproteins are anchored in the membrane and appear as protruding spikes 
on the virion surface, the matrix protein is non-glycosylated and is 
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peripherally attached to the inner surface of the envelope (Millar et al 1988). 
The nucleo protein is the most abundant protein in the virus particles and 
together with genomic RNA makes up the core helical nucleo capsid 
structure of NDV. The genomic RNA is associated with the NP, P and L 
protein to form the ribonucleo protein complex (RNP), which serves as a 
template for RNA synthesis (Yusoff and Tan, 2001). 
The peplomers of paramyxoviruses are composed of two glyco 
proteins: a hemagglutinin-neuraminidase protein (HN) and fusion protein (F) 
(Murphy et al, 1999). The HN glycoprotein possesses both hemagglutinin 
and neuraminidase activities and is involved in virus attachment (Scheid and 
Choppin, 1973, Seto et al, 1973). The (F) protein is responsible for the virus 
penetration (Scheid and Choppin, 1974; Knutton, 1978) and has been shown 
to mediate virus-induced hemolysis and cell fusion (Trybala, 1987). The HN 
and F polypeptides are derived from precursors HNO and FO, by proteolytic 
cleavage (Beard and Hanson, 1984).  
2.3.2.4 Virus replication  
First, the virion attached to cellular sialoglycoprotein or glycolipid 
receptor by its hemagglutinin-neuraminidase protein (HN), that shares with 
fusion protein (F) in the fusion process at physiologic PH, although its 
interaction with F protein is still controversial (Cobaleda et al, 2002), 
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(Murphy et al, 1999). Studies revealed that a virus-type specific HN-F is 
necessary for efficient fusion process (Horvath et al, 1992; Hu et al, 1992), 
while another study said that the fusion process in a reconstituted viral 
envelope is exclusively (F) dependant (Cobaleda et al, 2002), the HN protein 
composed of three domains, an external large hydrophilic glycoprotein 
which contains stalk region and functional sites for cell attachment and 
neuraminidase activity (Takimoto et al, 2000),  and two small 
transmembrane hydrophobic and internal hydrophilic domains (Sakaguchi et 
al, 1989; Morrison and Portner 1991). The fusion protein(F) is produced as a 
precursor protein F0 which should be cleaved by tissue or host cell protease 
during transcription through the Golgi membranes into two disulphide linked 
F1 and F2 forms or subunits (Morrison and Portner, 1991), this process is 
necessary for viral spread to other cells (Seal et al, 2000).  After penetration, 
the nucleocapsid complex enters the cell (Alexander, 1997). The RNA-
dependant RNA- polymerase (transcriptase) synthesizes RNA 
complementary to that of viral nucleocapsid (Alexander, 1997), which acts 
as messenger RNA and utilizes the cell’s mechanism enabling translation 
into proteins and virus genome (Alexander, 1997). 
Intracellular virus replication takes place entirely within the cytoplasm 
(Alexander, 1997), and reaches its maximum in 5-8 hr and liberation of virus 
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starts 4 hr post infection (Beard and Hanson 1984). The viral proteins 
synthesized in an infected cell are transported to the cell membrane where 
they become incorporated, and as a result modify the cell membrane 
(Alexander, 1997). Following alignment of nucleocapsid close to modified 
regions of cell membrane, virions are budded and released from the cell 
surface (Alexander, 1997; Peeples, 1988). 
2.3.2.5 Virus biological and physical properties 
There are properties that characterize NDV from other myxoviruses, 
and it distinguishes different strains of NDV from each other (Beard and 
Hanson, 1984). The properties are: 
2.3.2.5.1 Hemagglutination activity 
NDV and other avian paramyxoviruses have the ability to agglutinate 
erythrocytes , due to the binding of the hemagglutinin-neuraminidase (HN) 
protein to the receptors on the surface of the red blood cells (Alexander, 
1997).The hemagglutination and specific inhibition of it by antisera 
(Burnet,1942) are very important diagnostic tools (Beard and Hanson 1984; 
Alexander, 1997). 
The hemagglutinin and neuraminidase are found on the same 
polypeptide, so they cannot be separated from each other (Scheid, and 
Choppin, 1973). The hemagglutination (HA) process has two phases: 
  17
agglutination and elution, the agglutination concerned with the attachment of 
virus to the receptor substance on the red blood cell surface, the elution 
concerned with the destruction of the receptor substance by the enzyme 
neuraminidase and release of virus from surface of the cell (Beard and 
Hanson, 1984). The rate of elution may be measured by repeatedly 
resuspending cell until agglutination no longer takes place in a series of 
virus dilutions. It may be complete within 30 minutes or may take more than 
24 hours, depending on the strain of virus (Hanson 1980).  
NDV agglutinates erythrocytes of all amphibian, reptilian and avian 
types (Lancaster, 1966). Winslow et al, (1950) showed that human, mouse 
and guinea pig RBCs were agglutinated by all NDV strains tested, but the 
ability to agglutinate cattle, goat, sheep, swine and horse cells varied with 
the strain of NDV. 
The HA activity of specific strains of virus is usually more stable than 
its infectivity (Hanson, 1975). The hemagglutination of most strains is 
changed only slightly by an exposure to 0.1% formalin that destroys the 
infectivity (McCollum and Brandly, 1955).  
There is considerable variation in the thermal resistance of NDV at 
56oC, some strains lose their HA activity in 5 minutes whereas others retain 
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it for more than 240 min. (Hanson et al, 1949). Infectivity is lost in 30 to 90 
min (Hanson, 1975). 
2.3.2.5.2 Hemolysis 
NDV and other paramyxoviruses can lyses erythrocytes that it can 
agglutinate (Beard and Hanson, 1984; Alexander 1997).Hemolytic activity 
of virus preparation is enhanced by freezing and thawing, dialysis, sonic 
vibration and osmotic shock (McCollum and Brandly 1955). Salt 
concentration and PH of the suspending solution and temperature at which 
the reaction takes place are important (Beard and Hanson, 1984). 
2.3.2.5.3 Pathogenicity  
Newcastle disease virus has the ability to cause pathogenic effects in a 
host cells in the absence of multiplication (Burnet 1942). Toxic response of 
NDV can be shown by intracerebral (IC), intranasal, and intravenous (IV) 
application of the virus in mice and intravenous injection in rabbits. 
Intracerebral injection of virus in mice, cause central nervous system 
disturbances, with paralysis within 2 days and death in 3 days (Beard and 
Hanson, 1984). Intranasal administration of the virus may induce pneumonia 
and death of mouse (Beard and Hanson, 1984). Intravenous injection in 
rabbits may cause lymphocytopenia and fever (Beard and Hanson, 1984). 
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2.3.2.5.4 Thermo stability 
  The virus deactivated within 1 minute at 100oC and at 56oC, HA 
activity and immunogenicity occurs within 5 minutes to 6 hours (Beard and 
Hanson, 1984). Thermo stability of NDV could be raised by subsequent heat 
treatment cycles (King, 2001).  
This property has been used to differentiate between virulent and a virulent 
strains (Alexander, 1997). Some strains of NDVs such as V4 and Ulster 
strains, showed relative heat resistance (Spalatin and Hanson, 1967), the 
hemagglutinin of these strains was stable for 120 minutes at 56oC  while the 
other lentogenic strains like B1, Lasota and F strains can survive only for 5 
minutes (Spradbrow, 1991).   
2.3.2.5.5 Changes in cell culture 
Most virulent strains of Newcastle disease virus (NDV) will grow in a 
wide range of cell culture systems (Alexander et al, 1988). In addition, NDV 
can grow in primary cells that of an avian origin (Bankowski, 1964), some 
cell lines of mammalian origin (Lancaster, 1966). However, the most 
common cell lines used for isolation of NDV are chicken embryo fibroblast 
(CEF) and chicken embryo kidney cells (Bankowski, 1964). 
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NDV can form plaques on cell monolayers (Schloer and Hanson, 
1968).  
The plaques are of two basic types: clear and red as well as intermediate 
turbid forms, and of several sizes ranging from 0.5 to 4mm in diameter 
(Beard and Hanson, 1984). Plaques form in 2-7 days depending on strain 
virulence and influence of environmental conditions (Schloer and Hanson, 
1968). Velogenic and mesogenic strains are cytopathic and form plaques in 
CEF in 96 hours (Beard and Hanson, 1984). Lentogenic strains are 
cytopathic but rarely form plaques without adding magnesium (Mg) and 
diethylaminoethyl dextran (DEAD) to overlay media (Beard and Hanson, 
1968). 
 2.4 Epidemiology 
Assessment of the prevalence of ND in the world at any given time is 
extremely difficult. In some countries or areas, disease is not reported at all 
or only reported if outbreaks occur in commercial poultry, while the 
presence of disease in village chickens or backyards flocks is ignored. In 
some countries, the distribution is especially confused by the use as live 
vaccines of viruses that would be considered sufficiently virulent in other 
countries to be defined as ND when infecting poultry (Alexander et al, 
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2000). The greatest impact of ND may well be on village or backyard 
chicken production (Spradbrow, 1993)  
In developing countries throughout Asia, Africa, Central America  
and some parts of South America the village chickens is an extremely 
important asset representing a significant source of protein in the form of 
eggs and meat. However, ND is frequently responsible for devastating losses 
in village poultry. For example, Spradbrow (1992) estimated that each year 
90% of the village chickens in Nepal die because of ND (Alexander et al, 
2001). 
2.4.1 Host range 
NDVs have been reported to infect animals other than birds, ranging 
from reptiles to humans (Kaleta et al, 1988). Kaleta and Baldauf concluded 
that NDV infections have been established in at least 241 species of birds 
representing 27 of the 50 orders of the class. All birds are probably 
susceptible to infection, but as stressed by Kaleta and Baldauf, the disease 
observed with any given virus may vary enormously from one species to 
another (Alexander et al, 2000). 
The host range of NDV represents approximately 236 species of pets 
and free-living birds, but domestic avian species (chickens, turkey, goose, 
duck, and pigeon beside parrots) are mostly affected. The less affected 
  22
species are penguins, owls, falcons, eagles, storks, sparrows and songbirds 
while waterfowl, koels, shags, gulls, coots and cranes are least affected 
(Kaleta et al, 1988). 
2.4.2 Reservoirs 
Migratory feral birds may be responsible for the primary introduction 
of infection, but nearly all NDV isolates obtained from these birds are of low 
virulence. A more significant role of such birds may be the transmission of 
virus within an area following NDV infection of poultry (Alexander et al, 
2000). 
There appears to be two main reservoirs of NDV, the avirulent virus 
mainly associated with waterfowl, and the highly virulent viruses associated 
with tropical birds. Both are associated with growth in the intestines 
(McFerran et al, 1988).  
2.4.3 Transmission  
The way of transmission of the virus between birds is dependant on 
the organs in which the virus replicates (Jordan, 1990). 
The routes of transmission are: 
2.4.3.1 bird-to-bird transmission 
In countries were birds are kept in open range they are subjected to 
infection with strains carried by feral birds (Alexander, 1997). Free-range 
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pigeons and pheasants spread NDV from farm to farm (Beard and Hanson, 
1984). A pigeon virus strain has been described as being neurotropic for 
chicken (Alexander and Parsons, 1984). 
2.4.3.1.1 Respiratory route: 
Although the administration of live vaccines by aerosol demonstrates 
clearly that infection may be established via the respiratory route, 
remarkably little experimental evidence exist to suggest that infected birds 
will pass on the virus to susceptible birds in this way, even over short 
distances. The success of this route of transmission will depend on many 
environmental factors, such as temperature, humidity, and stocking density 
(Alexander et al, 2000). 
 Inhalation transmission of pneumotropic viruses occur due to 
aerosols set by infected birds (Beard and Hanson, 1984), via inhalation of 
droplets containing virus which will be liberated from infected birds as a 
result of virus replication in the respiratory tract, or as a result of dust and 
other particles including dried faeces (Alexander, 1997). On the other hand, 
because of drinking contaminated drinking water, as with vaccination with 
this medium (Alexander et al, 1988). 
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2.4.3.1.2 Contamination with faeces  
Spread of the disease this way was shown to be due to food 
contamination with faeces (Alexander et al, 1988), or by direct ingestion of 
contaminated faeces when virus restricted to intestinal replication (Jordan, 
1990). This is likely the main way of bird-to-bird spread for virulent enteric 
NDV and the pigeon variant virus (Alexander, Parsons and Marshall, 1984). 
It has been demonstrated that NDV will survive for 6 months or more in 
avian faeces under normal temperatures (Vindevogel et al, 1988). 
 2.4.3.1.3 Vertical transmission  
The significance of vertical transmission of NDV is still controversial. 
Infected embryos from naturally infected layers with virulent virus were 
reported (Lancaster and Alexander, 1975; Beard and Hanson, 1984). There 
is a report of infected chicks hatched from eggs infected with lentogenic 
vaccine viruses (Coman, 1963; French et al, 1967). LaSota strain was 
isolated from the reproductive organs after vaccination (Raszewska, 1964). 
Cracked or broken infected eggs may serve, as a source of virus for newly 
hatched chicks, there may be confusion comes from contamination of the 
eggs by faeces (Alexander, 1997). The virus may penetrate the shell after 
laying (Williams and Dillard, 1968). Embryos that survive V4 strain 
infection in ovo hatched and the progeny were NDV positive. More recently 
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virulent NDV was detected in uninfected cell cultures prepared from 
embryonated chicken eggs. However, chicks hatched from eggs collected 
from NDV infected flocks were virus negative even though dead embryos 
and infertile eggs in the same incubator contained NDV (Seal et al, 2000). 
2.4.3.2 Transmission from birds to humans 
Many of the documented cases involved infections in laboratory 
workers who accidentally splashed high titer NDV infected egg fluids into 
their eyes, veterinary diagnosticians who performed postmortem 
examinations on infected birds or handled infectious tissues, workers in 
poultry processing plants, and poultry vaccination crews (Swayne et al, 
2003). 
2.4.3.3 Transmission from humans to birds  
Man may transfer NDV either mechanically on his person or 
equipment, or because of an infection, which is usually manifest as 
conjunctivitis (Alexander et al, 1988). The spread could be by the movement 
of live birds, fomites, personnel, and poultry products (including dead birds 
and faeces for fertilizer) from affected premises to susceptible birds (Jordan, 
1990).  
No evidence exists to support human-to-human transmission, but the 
potential for human to bird transmission exists (Swayne et al, 2003). 
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2.5 Pathotypes of the disease 
NDV has many strains that vary at virulence. These strains started 
from highly virulent epizootic (velogenic) strains causing absolute mortality, 
and extending to avirulent lentogenic strains, which cause no clinical 
symptoms (Hanson, 1972; Lancaster and Alexander, 1975).  
Hanson and Brandly (1955) suggested that strains of NDV could be 
conveniently grouped as “velogenic”, “mesogenic” and “lentogenic” based 
on chicken embryo mortality at < 60hr, 60-90hr and >90hr respectively after 
allantoic inoculation. 
Beard and Hanson (1984) defined the following five groups based on 
clinical signs: 
1-Viscerotropic velogenic: it is also known as Doyle’s form, or some times, 
it is called Asiatic NDV. Viruses responsible for this type of the disease 
characterized by acute lethal infections, usually with hemorrhagic lesions in 
the intestines and digestive tract of the dead bird, with high mortality rate for 
all birds ages (Doyle, 1927). 
2- Neurotropic velogenic: It is also known as Beach’s form. Viruses cause 
the disease characterized by high mortality, which follows respiratory and 
neurological disease, but the gut lesions are usually absent. This form is 
formerly known as pneumoencephalitis (Beach, 1942). 
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3- Mesogenic: It is known as Beaudette’s form. It is the acute respiratory 
and some times lethal nervous infection of young chicks. Mortality is rare in 
older birds. Some strains of this form are used as vaccines (Beaudette and 
Black, 1946). 
4- Lentogenic: It is called Hitchener’s form. It is a mild or in apparent 
respiratory infection of chickens, the mortality rate is rare. Lentogenic 
strains are widely used as vaccines (Hitchener and Johnson, 1948).  
5- Avirulent: (Lancaster, 1981). The virus replication appears to occur 
primarily in the gut. It is detectable only by virus isolation from the gut or 
faeces and by presence of specific antibodies (French et al, 1967; Simmons, 
1967).  
2.5.1 Pathogenicity 
The pathogenesis of NDV depends on a number of factors, which the 
most important are the virulence, and tropism of the virus. Other factors, 
which may influence the morbidity, mortality and clinical signs, are the age 
of the bird, the immune status of the birds, route of exposure, magnitude and 
duration of the infecting dose, the susceptibility of the host species, and 
external factors such as temperature (Alexander, 1991, 1997). 
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2.5.2 Pathogenesis mechanism 
Virus enters the body via the respiratory and intestinal tract. In the 
trachea, the virus is spread by ciliary action and by cell-to-cell infection. 
Some strains multiply only in the intestinal tract and are exerted with the 
faeces. Subsequent spread largely depends on strain virulence. While 
lentogenic strains are present only at low titers in the circulation, mesogenic 
strains spread to kidney, lung, bursa, and spleen. Virulent virus can be found 
within 22 to 44 hours in practically all tissues, with highest titers in the 
thymus, and lowest in muscles and brain. After initial multiplication at the 
introduction site, virulent virus is carried by viraemia to spleen, liver, 
kidney, and lung. Virus invades the brain after multiplication in non-nervous 
tissues has ceased (from 60 hr after infection) where upon birds start dying. 
During the second multiplication following the arrest period, virus is once 
again released into the blood stream. This is associated with the appearance 
of general disease signs and excretion into the environment with exhausted 
air and faeces. Viruses of some strains reach vital organs like liver and 
kidney very rapidly, so that the birds may die before disease symptoms are 
overt. The sequence in which tissues are infected explains why nervous 
symptoms occur after the respiratory, intestinal, and general signs. Most 
viruses reach the CNS via the blood before significant amount of antibody 
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circulate. However, virulent neurotropic viruses may be present in the CNS 
at the same time as in the respiratory or intestinal tract (Kouwenhoven et al, 
1993). 
2.6 Incubation period 
Incubation period is 4 to 6 days. (OIE disease information: Newcastle 
disease) 
2.7 Prognosis  
In poultry, the disease can cause high mortality (up to 100%). 
Surviving birds show impaired growth, poor food utilization, reduced egg 
production, and impairment of eggshell formation. Fertility and hatchability 
of eggs are also reduced (Gallili et al, 1998).  
2.8 Clinical signs 
The clinical signs can be divided into reproductive, respiratory, 
enteric, and nervous signs.  
The reproductive signs: The effect on production is usually marked. 
There can be a reduction in egg numbers associated with smaller eggs, 
misshapen and rough shelled eggs and shell-less egg, and a decrease in the 
quality of albumen. In other outbreaks, the egg production can rapidly cease 
or fall to very low levels. This is usually preceded by the production of shell, 
less egg. Egg production often returns to normal levels after 3-4 wks, but in 
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some outbreaks, it never returns. In some cases, surviving birds may go into 
moult (McFerran et al, 1988). 
The respiratory signs may occur as mild rales and snicks, which only 
can be detected with careful observation. This is best heard at night when 
birds are settled. Signs may be more severe with sneezing, coughing, nasal 
discharges, and labored breathing to frank respiratory distress with open-
mouthed breathing. Inspiration can be accomplished by a rattling sound. 
Head shaking, with birds trying to dislodge mucus form the respiratory 
passages can be a feature. There may be a uni or bilateral mucopurulent 
conjunctivitis (McFerran et al, 1988). 
The most significant sign in the enteric form is diarrhea, it is greenish-
yellow one of some outbreaks, but is by no means a universal sign 
(McFerran et al, 1988). 
The nervous signs are variable and usually are not seen until the 
disease is advanced. They include tremors, torticollis, opisthotonus, 
convulsions that are steady and rhythmic uncoordinated movement and 
paralysis of wings or legs (McFerran et al, 1988). 
2.8.1 Viscerotropic-velogenic type 
With extremely virulent viruses, the disease may appear suddenly, 
with high mortality occurring in the absence of other clinical signs (Jordan, 
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1990; Alexander, 1997; Beard and Hanson, 1984). In outbreaks in chickens 
due to this pathotype, clinical signs often begin with listlessness, increased 
respiration, and weakness, ending with prostration and death (Alexander, 
1997; Beard and Hanson, 1984). 
 This type of ND may cause edema around the eyes and head. Green 
diarrhea is frequently seen in birds that do not die early in infection, and 
prior to death, colonic spasms, muscular tremors, toriticollis, paralysis of 
legs and wings, and opisthotonos may be apparent (Beard and Hanson, 1984; 
Alexander, 1997). Mortality reaches 100% in flocks of fully susceptible 
chickens (Murphy et al, 1999; Alexander, 1997). In outbreaks involving 
velogenic virus, birds may be found dead without any signs (McFerran et al, 
1988).  
The general symptoms begin with loss of appetite progressing to 
failure to eat and abnormal thirst, and severe dehydration and emaciation 
may occur in association with fever. Fluffed feathers, huddling, listlessness, 
somnolence, progressing to complete depression. Birds often sit on their 
hocks with their eyes half to fully close. Edema of the face (especially of the 
eyelids) is some times seen with velogenic strains and therefore can no 
longer be considered diagnostic for fowl plaque. Change of voice, becoming 
harsh, is some times followed by complete silence in the house due to the 
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depression of birds. Diffuse congestion of the skin with localized areas of 
petechiation, especially in the wattles can be a feature. Combs and wattles 
can become cyanotic and edematous due to a combination of respiratory and 
circulatory involvements (McFerran et al, 1988).    
2.8.2 Neurotropic-velogenic 
In chickens, it appears suddenly and spreads rapidly (Beard and 
Hanson, 1984). 
 Respiratory distress, coughing and gasping are marked, followed a 
day or two later by neurologic signs. Egg production falls dramatically 
(Beard and Hanson, 1984; Alexander, 1997), but diarrhea is usually absent. 
Morbidity may reach 100%. Mortality is generally considered much lower, 
although up to 50% in adult birds and 90% in young chickens has been 
recorded (Alexander et al, 1993) (Beard and Hanson, 1984). 
2.8.3 Mesogenic  
Mesogenic strains of NDV usually cause respiratory disease in field 
infections with marked coughing, but no gasping. In adult birds, there will 
be a loss of appetite with marked drop of egg production and quality (beard 
and Hanson, 1984). 
 Nervous signs may occur but are not common (Jordan, 1990). 
Mortality in fowl is usually low, except in very young and susceptible birds, 
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but may considerably affected by exacerbating conditions (Alexander et al, 
1993). 
2.8.4 Lentogenic  
Lentogenic viruses usually do not cause disease in adults. In young 
fully susceptible birds, serious respiratory disease problems can be seen, 
often resulting in mortality, following infection with more pathogenic 
LaSota strains a range of other microorganisms. Vaccination or infection of 
broilers close to slaughter with these viruses can lead to coli septicemia or 
air sacculitis, with resulting condemnation (Alexander et al, 1993). 
2.9 Diagnosis 
The objectives in the diagnosis of NDV infections are to reach a 
decision whether or not to impose control measures, and to obtain evidence 
to support epidemiological investigations. 
 None of the clinical signs, or lesions of ND may be regarded as 
pathognomic, and the wide variation in disease with virus strain, host 
species, and other factors means that at best, these can serve as only 
suggestion of infection with NDV strains in birds in most countries, and the 
almost universal use of live vaccines means that mere demonstration of 
infection, without definition of the infecting virus, is rarely adequate cause 
for control measures to be imposed (Alexander et al, 1993). 
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2.9.1 Laboratory diagnosis 
2.9.1.1 Isolation and identification of the virus 
2.9.1.1.1 Collection of samples 
Specimens for attempting isolation of the virus should be taken from 
infected chickens during incubation stage and early clinical stages of the 
disease, because virus rapidly disappears from tissues of the host on the 
development of demonstrable circulating antibodies (Hofstad, 1951), and 
some times is detected during the convalescent stage in the brain and in 
excretions when circulating antibody is present (6-21 days) (Walker and Mc 
Kercher, 1954).  
Sampling from live birds for virus isolation should consist of either 
cloacal swabs (or faeces) and tracheal swabs and from dead bird’s intestines, 
intestinal contents, tracheas, and organs and tissues obviously affected or 
associated with clinical signs (Jordan, 1990).  
   2.9.1.1.2 Virus propagation in cell culture 
For propagation of NDV from field samples, the allantoic cavity of 
embryonated chicken egg and different types of cell and organ cultures are 
commonly used (Paul and Hope, 1979). Different types of cytopathic effects 
(CPE) were usually observed. Syncytia and complete destruction of cell 
monolayer is common. However, some ND viruses did not produce 
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cytopathic effect (Durand and Eisenstork, 1962). If less virulent virus were 
suspected to be present trypsin should be added to maintenance medium to 
promote growth and multiplication of the virus.The embryonated chicken 
eggs are preferred to chicken or other animals for isolation of NDV (Hanson, 
1980). 
Chicken embryo fibroblast cells are also used for isolation, and it is 
determined by appearance of distinctive plaques (Schloer and Hanson, 
1968), or inoculating egg bit cultures, and the isolation is determined by 
presence of hemagglutinin (Beard, 1969). 
2.9.1.1.3 Virus identification  
The tests which are used including hemagglutination inhibition test 
(Burnet, 1942), single radial immuno diffusion (Chu et al, 1982), agar gel 
precipitin (Gelb and Cianci, 1987), virus neutralization in chick embryos 
(Beard, 1980), plaque neutralization (Beard and Hanson, 1984), and 
enzyme-linked immunosorbant assays (ELISA) (Snyder et al, 1984). 
2.9.1.2 Differential diagnosis 
New castle disease can be confused with other respiratory diseases of 
poultry such as infectious bronchitis, laryngotrachitis, mycoplasmosis, 
coryza, and avian influenza including fowl plague (Beard and Hanson, 
1984). Central nervous system disturbance of ND resembles some features 
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of avian encephalomyelitis, Marek’s disease and certain poisoning (Beard 
and Hanson, 1984). 
There are no gross or histological changes that can be considered 
pathognomic of ND (Beard and Hanson, 1984). Thus, diagnosis requires 
laboratory tests either isolation or identification of the virus and 
reproduction of the disease or demonstration of specific increase in antibody 
level associated with recovery from infection. 
NDV can be differentiated from other paramyxovirus serotypes by use 
of the HI test with specific monoclonal antibodies (MAbs) directed against 
strains of NDV isolates (Alexander, 1990). 
2.10 Control 
The control measures had been arisen because of the bad effect of ND 
on poultry trade and industry after many outbreaks. First many countries 
imposed strict regulations for introduction of birds and later produced 
vaccines and develop a vaccination programs (Alexander, 1992). However, 
proper control measures for ND should be based fundamentally upon an 
adequate diagnosis. That means just isolation or detection of virus or 
serological evidence of infection are sufficient , and characterization of virus 
virulence at any level is essential for planning control procedures as they 
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differs between virulent and a virulent viruses (Aldous and Alexander, 
2001). 
The appropriate combination of vaccination and prevention 
procedures is the most satisfactory approach for ND control (Chu and Rizk, 
1972). Such procedures include good husbandry, hygiene and biosecurity 
(Young et al, 2002). 
Biosecurity aimed at preventing disease should commence at the 
planning stage of commercial poultry farms. Farms and flocks should be 
well separated, hatcheries should be isolated from poultry farms, different 
species should be reared on different sites, and an adequate fresh water 
supply should be available, preferably one that does not draw on surface 
water. 
 On poultry farms, the following points should be observed: 
a- bird houses, feed stores and water tanks should be bird- proofed. 
b- movement in and off the farm should be kept to a minimum. 
c- All equipment, especially vehicles, should be disinfected before access to 
the site is permitted. 
D- Movements between different farms for egg collection, carcass 
collection, and feed delivery and similar should be to and from a specified 
collection and delivery point away from the poultry flocks. 
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Visits from personnel such as bleeding or vaccination teams, 
inseminators and veterinarians are the most likely method of introduction of 
ND. If such visits are unavoidable, regimens of clothing change, equipment 
disinfection and other basic hygiene controls must be enforced (Alexander et 
al, 2000). 
Two main control measures are adopted for Newcastle disease, which 
are stamping out policy (which is combination of quarantine and slaughter) 
and vaccination policy. The choice between the two measures depends on 
the economic situation of the country, importance of  the poultry industry 
and the ubiquity of the virulent strains of NDV. The developed countries 
conduct the first type of control programme successfully, while the 
developing countries resort to control by vaccination (El Hassan and 
Mahasin, 1995).  
The infectivity of NDV and other paramyxoviruses may be destroyed 
by physical and chemical treatments such as heat, irradiation (including light 
and ultraviolet rays), oxidation processes, PH effects and other various 
chemical compounds (Alexander et al, 1993).  
No single treatment can guarantee destruction of all viruses, but may result 
in low probability of infective virus remaining (Alexander et al, 1993). 
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2.11 Newcastle disease in Sudan 
Newcastle disease is figured as the most devastating disease of poultry 
in the Sudan (Anon, 1982). It was first reported in Sudan in 1952 (Ali, 
1978). It is endemic in Kordofan region (Suliman and Sobhi, 1988). 
 NDV was isolated and identified for the first time by Karrar and 
Mustafa in 1964. Partial characterization of NDV isolates was made by Eisa 
(1979), and Ballouh et al, 1983. 
 Khogali, 1971 studied the disease in exotic and local breads of 
chicken in Khartoum province. Ballouh and Nayil, 1983 pathotyped NDV 
isolates in the Sudan during the period 1963-1976 using the methods 
described by Anon, 1971. Eight of the isolated viruses were found to be 
velogenic and four were mesogenic. Khalafalla, Fadol, Hamid, Hussein and 
Mahasin (1992) found that velogenic viscerotropic NDV is the most 
prevalent NDV strain in the Sudan, which is responsible for the heavy 
annual losses of the country’s poultry industry. 
In the Sudan, Newcastle disease is controlled mainly by vaccination 
and use of sanitary measures (El Hassan and Mahasin 1995). 
Considerable efforts were made to control disease in fowl through 
vaccination programmes (Karrar and Mustafa, 1964; Ali, 1978; Mahasin et 
al, 1980).  
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Vaccine in current use is prepared from Komarov strain of NDV and 
chickens receive the first dose of vaccine at 4 weeks of age with subsequent 
booster dose at 4 month of age (Ali, 1978). Eisa, 1979 and Gaffer Elamin et 
al, 1981 studied the effectiveness of ND vaccination programme using the 
Komarov vaccine strain. 
 In Sudan, besides domestic fowls, NDV has only been isolated from 
naturally infected pigeons (Eisa and Omer, 1984), and from experimentally 
infected Passeriformes (Khalfalla, Nayil, Nimir and Hajer, 1990). 
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CHAPTER TWO 
MATERIALS AND METHOD 
2.1. Plant material 
The plant used in the study was (Acacia nilotica)  sub species 
tomentosa, which is locally known as (Garad) and it was obtained from the 
local market- Omdurman. 
 Wael Alsadig Abdalla from Medicinal and Aromatic Plant Research 
Institute (MAPRI) authenticated the plant. 
 In chapter one the plant had been described with its botanical 
description, family, vernacular name and folkloric uses. 
The part used of the plant was fruits. 
500 grams of the plant sample were powdered by manual grinder and 
extracted with different solvents and water as will be described in the 
experimental section, then subjected to antiviral activity. 
2.2 Preparation of the plant extracts 
Two solvents (methanol and chloroform), and water were used for 
extraction of the crude plant. 
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2.2.1. Methanol and chloroform extracts 
Lab TECH chemicals manufactured the chloroform used, and its 
scientific name is trichloromethane (CHCl3), it is immiscible with water 
forming and it dissolved in dimethyl sulphoxide (DMSO). 
The methanol used manufactured by BGH chemical- India, and it is miscible 
with water forming. 
The extracts were prepared by using Soxhlet extraction unit as per the 
standard procedure, and this carried out in the Industrial research and 
consultancy centre-Shambat. 
  The coarsely powdered plant material (50g) was exhaustively 
extracted for 20 hours with chloroform in soxhlet apparatus. The chloroform 
extract was filtered and evaporated under reduced pressure using Rota-vap. 
The extracted plant material was then air- dried, repacked in the soxhlet and 
exhaustively extracted with methanol.   
The methanolic extract was filtered and evaporated under reduced 
pressure again using Rota-vap. After that, the two extracts were put in an 
open dish to allow the evaporation of the solvents and the remaining was the 
extract ready to use. 
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2.2.2. Water extract 
The plant had been extracted by the maceration method, and the 
extraction had been carried out at the phyto chemistry laboratory in the 
medicinal and aromatic plants research institute (MAPRI). 
400grams of coarsely powdered plant material was used for water 
extraction. One liter of boiled distilled water DWW was added to the plant 
and left for 3 hours, then filtered by filter paper and put in the freeze-drier. 
The extract then was ready to use, and should be stored in a dry place. 
2.3. The virus 
Freeze-dried, live, chick- embryo adapted vaccine containing 
komarov strain (K) of Newcastle disease virus NDV was used. 
The viral vaccine unit, centre of veterinary research laboratories- 
Soba, kindly supplied the vaccine. 
2.4. Laboratory work 
2.4.1 Sterilization of glassware 
Glass ware like beakers, flasks, centrifuge tubes, bijou bottle were 
rinsed in tap water and all solid matter washed away, then they washed by 
hot water with detergent and rinsed in running water for 5 times to remove 
detergent completely. After that, they were rinsed in five changes of distilled 
water, left dry and finally sterilized in the oven at 180oC for 2 hours. 
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2.4.2. Sterilization of plastic ware 
Plastic wares like screw caps are sterilized by autoclaving at 121C for 
30 minutes. 
Solutions and media used are also sterilized by autoclaving. 
2.5. Vero cells 
  Vero cells are an established cell line whose source is African green 
monkey kidney cells were used; they were obtained from central laboratories 
of veterinary research- Soba, viral vaccine unit. 
Vero cells were used for propagation, cytotoxicity assays, antiviral activity 
assays and titration of the virus. 
Vero cells were first sub cultured in 25 ml Nunclon tissue culture 
flasks, and were grown in glassgow minimal essential medium (GMEM), 
with anti biotics and anti fungal added, and was supplemented with 10% of 
heat inactivated newborn calf serum (NBCS) which manufactured by sigma- 
labs to form semi confluent monolayer. 
The cells were maintained at 37oC in a humidified atmosphere with 
5% NBCS and were sub cultured twice a week. 
The cells, medium, trypsin, NBCS, antibiotics, and anti fungal were 
obtained from the central laboratories for veterinary research- viral vaccine 
unit. 
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The virus was adapted to this cell-line by 2-3 successive passages. 
The monolayer cells were infected for 60 minutes with komarov vaccine 
strain, but first the lyophilized vaccine was dissolved in 1 ml of GMEM, and 
the infective titer of the stock solution was 10-5 (TCID50), the TCID50 was 
calculated by Reed-Muench method. 
Cytopathic effect (CPE) has been observed after 48 hours from 
infection. 
When CPE appeared and reached 80%, one freezing and thawing cycle have 
been done followed by centrifugation and the cell-free supernatant had been 
kept at -70oC until be used. 
2.6. Cytotoxicity tests 
2.6.1 Preparation of stock solution of chloroform extract 
First 0.01 gram from the chloroform extract were weighed, then it was 
dissolved in 1 ml of distilled dimethyl sulphoxide (DMSO) and the volume 
was made up to 10 ml with maintenance medium to obtain a stock solution 
of 1000µg/ml concentration. 
2.6.2 Preparation of stock solution of methanol and water extracts 
0.01 gram of each extract was separately weighed, and then they were 
dissolved in 10 ml of sterile distilled water to obtain a stock solution of 
1000µg/ml concentration. 
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2.6.3 The cytotoxicity assays 
The cytotoxicity assays were carried out using 2ml of cell suspension 
in the GMEM with 10% of NBCS, and they were seeded in 12-well 
polystyrene plate (manufactured by Corning), and then left for 24 hours to 
form a monolayer. 
A disposable filter holder of 0.22µm was filtered 1 ml from each stock 
solution of each extract, and five more dilutions were made from them 
(maximum 200µg/ml, and the minimum 0.32µg/ml). 
Medium containing different concentrations of the test samples was 
added after 24 hours of seeding. Control cells were incubated without test 
samples, and the control cells of the chloroform extract were incubated with 
DMSO (the little percentage of DMSO present in the cells (maximal 0.2 %) 
was found not to affect the cells). 
The plates with the samples were incubated in a humidified incubator for a 
period of 5 days. Two wells were used for each concentration of the test 
sample. 
 The morphology of the cells was inspected daily and observed for 
microscopically detectable alterations, such as loss of monolayer, 
granulation and vacuolization in the cytoplasm. The cytopathic effect (CPE) 
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was scored. The non-cytotoxic concentration for the cells of each extract that 
does not reduce the viability of Vero cells was determined. 
 2.7. Antiviral assay 
The nontoxic concentrations of each extract were checked for antiviral 
property by examining them by optical microscopy, sub culturing the 
solution of the inhibitory concentration for the virus in new cells, and by 
haemagglutination test. 
Cells were seeded in 12- well plate, incubated in 37o C in a humidified 
incubator for a period of 48 hours. 
The plates were washed with GMEM and challenged with the virus and 
incubated in 37o C for 60 minutes for adsorption of the virus. The cultures 
were treated with the different dilutions of plant extracts in maintenance 
medium and incubated at 37o C for 3 days. 
In another 12-well plate, the different dilutions of the plant extracts 
were added directly to a little amount of the medium with the virus, 
incubated at 37oC for 60 minutes, and then the rest of the maintenance media 
was added and incubated again at 370C for 3 days. 
Every 24 hours the observation was made and cytopathic effect was 
recorded. Anti NDV activity was determined by the inhibition of cytopathic 
effect compared with control. The protection offered by the test samples to 
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the cells was scored. These trials were repeated for many times to each 
extract to confirm the result. 
2.8. Sub culture of the virus suspension 
A blind passage from the suspension of the methanol extract different 
inhibitory concentrations has been made, and the control was made of the 
blind passage for the suspension containing the virus with CPE already 
appeared and a control of healthy cells was also made.  
Cells were seeded in 6-well plate, and has been infected with the 
suspension for 60 minutes, a maintenance medium added, then incubated in 
37oC for 3 days, and every 24 hours the observation was made and 
cytopathic effect was recorded. 
2.9. Hemagglutination test (HA) 
This test was used to confirm the result of the inhibitory 
concentrations that had been sub cultured previously and to determine the 
titer of the virus before and after treating with the samples. 
The test was carried out according to OIE Manual, 1996. 
2.9.1. Preparation of 1% red blood cells (RBCs) 
Blood was collected aseptically from the wing vein of a healthy, non- 
immunized chicken in Alsever’s solution, and then the blood was 
centrifuged at 3000rpm for 10 minutes. Then, the supernatant was discarded 
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and equal volume of normal saline was added to RBCs pellet. The RBCs 
were resuspended and centrifuged at 3000 rpm for 10 minutes. This washing 
process was repeated 3 times and then 1% suspension of RBCs was prepared 
in sterile normal saline and stored at 4o C.   
2.9.2. Procedure of HA test 
0.025 ml of normal saline was placed into 96-well polystyrene U-
bottomed microtiter plate by a multichannel pipette.  
0.025 of the virus suspension (treated and not treated with the tested 
extracts) was placed in the first well of each row. The last row was left as a 
control without the tested suspensions, and then 0.025 of normal saline was 
added to each well again. 
Two fold dilutions of the virus suspensions were carried out across the plate. 
0.025 ml of 1% chicken red blood cells (RBCs) was dispensed to each well. 
Plates were tapped gently to mix the solutions and left at room temperature 
for 30 minutes. A row of the plate was containing the suspension of the 
extract without the virus. 
When control RBCs in the last row were settled, the hemagglutination 
titer of each suspension was recorded as the highest dilution showed 
complete hemagglutination. 
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2.10. Determination of tannin contents in the extracts 
The test was carried out in the food technology laboratory at the 
college of agriculture U of K.  
The samples were estimated using the Prussian Blue assay, as 
described by Price and Butler (1977).  
60mg of the grounded samples was extracted separately with 3 ml 
absolute methanol in a test tube, by constant shaking for one minute, and 
then poured into a filter paper. The tube was quickly rinsed with an 
additional 3 ml of methanol and the contents poured at once into the filter 
paper. The filterate  was diluted to 50 ml with distilled water, mixed with 3 
ml 0.1M FeCl3 in 0.1 N HCl for 3 minutes, followed the timed addition of 
3ml 0.008M K3Fe (CN)6. The absorption was read after 10 minutes at 720 
nm on a spectrophotometer. The absorbance for each extract was used to 
determine the equivalent amount of tannic acid and the percentage of tannin 
content in each extract was calculated as reported by Price and Butler, 
(1977). 
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CHAPTER THREE 
RESULTS 
3.1 Results of Cytotoxicity assay 
The cytotoxicity assay has been made for the three extracts 
(chloroform, methanol, and water) to determine the non-cytotoxic 
concentrations for Vero cells. 
Non-cytotoxic concentration for chloroform extract was ≥  200µg/ml. 
(Figure.1) 
Non-cytotoxic concentration for methanol extract was ≥  40µg/ml. 
(Figure.2) 
Non-cytotoxic concentration for water extract was ≥  40µg/ml. (Figure.3) 
3.2 Results of antiviral assay 
The methanol extract of Acacia nilotica was found to have an antiviral 
activity against Komarov vaccine strain of NDV in a concentration non-
toxic to the cell line used.  
This result was seen when using both ways of adding the virus, first 
by infecting the cells for 60 minutes with the virus, and then the media with 
the tested samples were added, the other way by treating the virus with the 
tested samples directly to the medium. (Figure.4) 
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Chloroform and water extracts failed to show any significant antiviral 
activity and the cells were made a significant CPE similar to the control cells 
infected with the virus. (Figure.5 and 6). 
3.3 Results of Sub culturing the virus 
The blind passage from the concentrations of the methanol extract that 
showed antiviral activity has confirmed the previous result, and there was no 
CPE, unlike the control with the virus that showed a significant CPE. 
(Figure.7). 
3.4 Results of the hemagglutination test 
The titer of the virus used as a control was 2 log 6. 
The titer of the virus treated with the tested samples was zero. (Figure. 8). 
 3.5 Results of tannin contents 
The percentage of tannin in the methanol extract was 1.6%. 
The percentage of tannin in the water extract was 1.2%. 
The tannin percentage in the chloroform extract cannot be determined. 
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Fig.1: Vero cells with non-toxic concentration of the chloroform 
extract (≥  200µg) (Vero appear normal). 
 
 
Fig.2: Vero cells with non- toxic concentration of the methanol 
extract (≥ 40µg) (Vero appear normal). 
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Fig.3: Vero cells with non-toxic concentration of water extract (≥ 
40µg) (Vero appear normal). 
 
 
 
Fig.4: Cells with the inhibitory concentration of the methanol extract 
(NDV shows no effect on Vero cells). 
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Fig.5: Complete CPE in Vero cells treated with chloroform extract 
 
 
Fig.6: CPE in Vero cells treated with water extract 
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Fig.7: Control Vero cells with CPE after the subculture 
 
 
Fig.8: Haemagglutination test 
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Fig.9: Diagrammatic representation of Newcastle disease virus 
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              Fig.10: Acacia nilotica tree 
 
                        
               Fig.11: Thorns and fruits of sub species tomentosa 
 
 
 
 
 
 
  59
 
CHAPTER FOUR 
4.1 Discussion 
The results from this study provided evidence of the importance of 
ethnopharmacology as a guide to the screening of biologically active plant 
materials (Farnsworth et al, 1981), and it indicates that methanol extract of 
Acacia nilotica  have significant inhibitory effect on the replication of NDV. 
Many attempts at screening traditional medicines have been made 
(Chang and Yeung, 1989; Otake et al., Wan et al, 1996). However, the 
Sudanese medicinal plants, with their vast diversity, have not been 
investigated for their antiviral activity (Hussein et al, 1999).There are a few 
reports on some of their biological activities such as antibacterial (Andrews, 
1952) and antimalarial activities(Khalid et al, 1986). There is only one study 
on the antiviral activity of the Sudanese plants that has been made by 
Hussein et al, 1999, in it he screened a number of the Sudanese plants 
against HIV and HIV-1 protease and it showed a considerable results. 
Being intracellular parasites, viruses need living systems to proliferate. 
They replicate themselves by actively using the cellular systems of their 
host. This makes it difficult to fight with viruses.The antiviral agent to be 
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used against viruses is desired to affect the virus but not to damage the host 
cell. 
There are several antiviral agents which disrupt the replication 
steps of viruses in infected cells, namely adhesion, endocytosis, 
decapsulation, nucleic acid synthesis, protein synthesis, fusion and leaving 
the cell. These antiviral agents are structurally purine or pyrimidine base 
analogous in general. They are known to inhibit adhesion of the virus on the 
cell surface, relieving from the protein coat, and some inhibit mRNA 
synthesis (Wood and Geddes, 1987; Dolin et al, 1982). 
 Among antiviral agents, amantadine inhibits adhesion of some 
viruses on the cell, idoxuridine inhibits replication of DNA viruses, and 
ribavirin most probably inhibits mRNA synthesis(Wood and Geddes, 1987; 
Dolin et al, 1982). Hypericin and rose Bengal substances are reported to 
inactivate replication of the Friend Leukemia Virus (FLV) (Nancy and John, 
1992). On the other hand, lamivudine, a nucleoside analog, significantly 
inhibits replication of HIV when used together with 3’-azido-3’-
deoxythymidine (ATZ) (Ricman, 1996). 
   In this study three different extracts of the Acacia nilotica sub species 
tomentosa, which is used in the folk medicine in Sudan, have been 
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investigated targeting their inhibitory effects on the Komarov vaccine strain 
of the Newcastle disease virus replication. 
  We used 100 percent inactivation to define an extract with antiviral 
activity. Of the three extracts tested, the methanol extract of the plant was 
found to exhibit potent antiviral activity, the cells in this case continued their 
normal growth and proliferation, but the replication of the virus was 
inhibited. The sub culturing of the virus treated by the extract, and the 
hemaggglutination test confirmed the result. Hemagglutination test showed 
that there is no titer for the virus at all compared to the control used. The 
water and chloroform extract were showed no effect on the virus tested. 
 However, these extracts may have partial antiviral activity. These extracts 
may have compounds that are true antiviral, but are present at quantities 
insufficient to inactivate all infectious viral particles and/or the uneven 
distribution of chemical constituents within these extracts may affect their 
efficacy. 
 The elucidation of active constituents in these plant extracts may 
provide useful lead to the development of new and effective antiviral agents. 
The methanol and water extract were tested for their tannin percentage, 
because tannins or poly phenols are thought to constitute one of the most 
important chemical components in the plant kingdom. The inhibitory 
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activity of tannins on NDV and/or its essential enzymes is considerable since 
many tannins and related compounds are known for their binding to proteins 
and this can explain the result of the hemagglutination test, that the tannin 
could be bonded to the hemagglutinin-neuraminidase protein existed in the 
virus envelope. 
 However, Zhu et al, (1997) recently reported that some tannins and 
related compounds had shown specific activity at the receptor level and that 
their removal from the plant extract prior to screening for receptor activities 
may result in missing biologically active compounds with specifity of action, 
and this may explain the action of tannin when the tested extract added to 
the virus directly in the medium, it may bonded either to the receptors or the 
proteins in the outer surface . 
In this study, the tannin contents of the tested plant extracts was 
determined by the Prussian Blue assay. Of the methanol extract that showed 
inhibitory activity on Komarov strain, it showed a higher content of tannin 
compared with the water extract.  
Since this is a preliminary study for the effect of plants on replication 
of viruses, it is better to utilize a non-pathogenic virus to humans and 
animals rather than pathogenic one. 
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Once any effective extract is determined, this substance can be 
purified and used on pathogenic virus. 
 
4.2 Future recommendations 
For thousands of years herbs have been used as medicine by cultures 
all over the world. Today, a large variety of indigenous medicinal plants 
have been shown experimentally to possess promising antiviral activities. 
This has created optimism about the future of phyto- antiviral drugs 
development. 
Today viral diseases are still fatal, although some can be under control 
with life- prolonging drugs. These expensive antiviral drugs are still far 
beyond the means of most developing countries. Arguably, the development 
of safe, effective and inexpensive antiviral drugs is the top global priorities 
of drug development, as many viruses are not curable and mortality rates are  
high, for example with HIV and hepatitis. Therefore, it is essential to 
continue the search for useful and novel natural antiviral agents. Recently 
considerable attention has been given to screening of various species of 
medicinal plants extracts for possible antiviral activity. 
When evaluating the antiviral activity of different chemical 
constituents  extracted from medicinal plants, one must consider the effect of 
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such variables as the extraction method, the parts of the plant used and the 
season of harvest. 
For future work : 
-different parts and different plants should be used and we can make a 
screening for many Sudanese plants against many human, animal and plant 
viruses. 
-Different methods of extractions can be used. 
-Different methods of diagnosis can be used. 
-We can try in-vivo experiments in different experimental animals or 
in embryonated eggs. 
-Use different types of cell lines.   
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APPENDICES 
Appendix I 
Tissue culture media and additives 
1. Antibiotics 
1.1  Penicillin- Streptomycin 
One gram of streptomycin and contents of two vials of Penicillin (106 
IU/vial) were dissolved in 10 ml of sterile DDW so that 1 ml of prepared 
solution contained 100 mg of streptomycin and 200.000 IU Penicillin. The 
solution was kept at -20oC. 
1.2. Gentamycin 
10 mg of Gentamycin was dissolved in 1ml sterile DDW. 
1.3. Mycostatin 
One vial mycostatin containing 500.000 units was dissolved in 10 ml of 
sterile DDW. 
2. Minimum essential media (GMEM) 5X 
Minimum essential medium powder of 125.7g was dissolved in two liters of 
sterile DDw and sterilized by filteration. It was dispensed in 0.5 liters 
amount and frozen at -20oC. 
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2.1.  Minimum essential media 1Xconc 
GMEM 5Xconc                    200 ml 
Lactalbumin hydrolysate        25 ml 
Yeast extract 1%                          25 ml 
Na HCO3 (7.5%)                     7-9 ml 
Penicillin, streptomycin, Gentamycin, mycostatin              4 ml 
DDW completed to         1000 ml 
2.1.1 Tissue culture additives 
2.1.1.1 Sodium bicarbonate (Na HCO3): 100 ml (7.5%) 
Na HCO3 powder                    6.5 gm 
DDW                                       100ml 
Autoclaved at 121oC for 30 minutes and cooled. 
It used for adjustment of PH. 
2.1.1.2. Yeast extract 1%: 100ml 
Yeast extract powder                      1gm 
DDW                                              100ml 
Autoclaved at 121oC for 30 minutes and cooled. 
2.1.1.3 Lactalbumin hydrolysate 5% 
Lactalbumin powder                             5gm 
DDW                                                       100ml 
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Autoclaved at 121oC for 30 minutes and cooled. 
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Appendix II 
Cell dispersing solution 
1. Trypsin 2.5% 
Was prepared by addition of 10ml of 2.5% trypsin to 90 ml of sterile 
phosphate diluent. 
2. Versene solution 5% 
 Was prepared by adding 5 gm of versene to 100 ml of sterile phosphate 
diluent. Autoclaved at 121oC for 30 minutes. 
3. Trypsin versene solution 
Trypsin (2.5%)           6.0 ml. 
Versene (5%)               4.0 ml. 
Completed by phosphate diluent to 100ml. few drops of sterile phenol red 
were added, and the PH was adjusted with 1M NaOH. 
4. Phosphate Diluent  
NaCl                                     16.0 gm 
KCl                                       0.4   gm 
Na2HPO4 (unhydrous)           2.3 gm 
KH2PO4 (hydrous)                 0.4gm 
DDW completed to 2000 ml. 
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The solution was autoclaved at 121oC for 30 minutes, left to cool and 
antibiotics were added. 
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Appendix III 
Haemagglutination test solutions 
1. Physiological saline (Normal saline) 
Nacl                                  8.5 gm 
DDw                                 1000 ml 
The mixture was autoclaved at 121oC for 30 minutes. 
Usually the PH of normal saline was 7.2 
2. Alsever`s solution (anticoagulant): 1 L 
D. glucose                                 20.5 gm 
Nacl                                          4.2 gm 
Na citrate                                   8.0 gm 
Citric acid                                0.55 gm 
The mixture was completed to one litre with DDW and autoclaved at 121oC 
for 30 minutes.  
 
